Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 [Yahoo! Finance]
Fulcrum Therapeutics, Inc. (FULC)
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
in markers of hemolysis and anemia, and encouraging trends in vaso-occlusive crisis (VOC) reduction ? ? Fulcrum plans to initiate a potential registration-enabling trial in the second half of 2026 ? ? Dosed first patient in an open-label, long-term dosing trial evaluating the long-term safety and durability of response to pociredir in participants previously enrolled in the PIONEER trial ? ? Appointed Josh Lehrer, M.D., M.Phil., FACC, an experienced leader in sickle cell disease drug development, to the Board of Directors ? ? Chief Financial Officer, Alan Musso plans to retire later this year and will continue in his role until a successor is named ? ? Ended the first quarter of 2026 with $333.3 million in cash, cash equivalents, and marketable securities; cash runway into 2029 ? CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules that im
Show less
Read more
Impact Snapshot
Event Time:
FULC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FULC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FULC alerts
High impacting Fulcrum Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FULC
News
- Fulcrum Therapeutics Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Fulcrum (FULC) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations [Yahoo! Finance]Yahoo! Finance
- Fulcrum Therapeutics GAAP EPS of -$0.25 beats by $0.05 [Seeking Alpha]Seeking Alpha
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026GlobeNewswire
FULC
Earnings
- 4/27/26 - Beat
FULC
Analyst Actions
- 2/24/26 - Leerink Partners
FULC
Sec Filings
- 4/27/26 - Form 10-Q
- 4/27/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- FULC's page on the SEC website